Literature DB >> 25932112

Functionalized nano-graphene oxide particles for targeted fluorescence imaging and photothermy of glioma U251 cells.

Zhong-Jun Li1, Chao Li1, Mei-Guang Zheng1, Jia-Dong Pan2, Li-Ming Zhang2, Yue-Fei Deng1.   

Abstract

AIM: This study was to prepare the functionalized nano-graphene oxide (nano-GO) particles, and observe targeted fluorescence imaging and photothermy of U251 glioma cells under near infrared (NIR) exposure.
MATERIAL AND METHODS: The functionalized nano-GO-Tf-FITC particles were prepared and then were incubated with U251 glioma cells. Estimation of CCK8 cell activity was adopted for measurement of cytotoxicity. The effect of fluorescein imaging was detected by fluorescence microscope with anti-CD71-FITC as a control. Finally, we detected the killing efficacy with flow cytometry after an 808 nm NIR exposure.
RESULTS: Both nano-GO-Tf-FITC group and CD71-FITC group exhibited green-yellow fluorescence, while the control group without the target molecule nano-GO-FITC was negative. The nano-GO-Tf-FITC was incubated with U251 cells at 0.1 mg/ml, 1.0 mg/ml, 3.0 mg/ml and 5.0 mg/ml. After 48 h of incubation, the absorbance was 0.747 ± 0.031, 0.732 ± 0.043, 0.698 ± 0.051 and 0.682 ± 0.039, while the absorbance of control group is 0.759 ± 0.052. There is no significant difference between the nano-GO-FITC groups and control group. In addition, the apoptosis and death index of nano-GO-Tf-FITC group was significantly higher than that of nano-GO-FITC and blank control group (P < 0.05).
CONCLUSION: The nano-GO-Tf-FITC particles with good biological compatibility and low cytotoxicity are successfully made, which have an observed effect of target imaging and photothermal therapy on glioma U251 cells.

Entities:  

Keywords:  Glioma; fluorescence imaging; graphene oxide; photothermy; transferring

Year:  2015        PMID: 25932112      PMCID: PMC4402759     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  29 in total

1.  Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.

Authors:  Jiang Chang; Archibald Paillard; Catherine Passirani; Marie Morille; Jean-Pierre Benoit; Didier Betbeder; Emmanuel Garcion
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

2.  A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia.

Authors:  Giammaria Fiorentini; Petros Giovanis; Susanna Rossi; Patrizia Dentico; Raffaele Paola; Gina Turrisi; Paolo Bernardeschi
Journal:  In Vivo       Date:  2006 Nov-Dec       Impact factor: 2.155

3.  Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy.

Authors:  Kai Yang; Shuai Zhang; Guoxin Zhang; Xiaoming Sun; Shuit-Tong Lee; Zhuang Liu
Journal:  Nano Lett       Date:  2010-09-08       Impact factor: 11.189

Review 4.  Neurosurgical approach.

Authors:  Jennifer A Moliterno; Toral R Patel; Joseph M Piepmeier
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

5.  Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.

Authors:  Sundeep Deorah; Charles F Lynch; Zita A Sibenaller; Timothy C Ryken
Journal:  Neurosurg Focus       Date:  2006-04-15       Impact factor: 4.047

6.  Electronic properties of nanodiamond decorated graphene.

Authors:  Yu Wang; Manu Jaiswal; Ming Lin; Surajit Saha; Barbaros Ozyilmaz; Kian Ping Loh
Journal:  ACS Nano       Date:  2012-01-18       Impact factor: 15.881

7.  Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.

Authors:  P Calvo; B Gouritin; H Chacun; D Desmaële; J D'Angelo; J P Noel; D Georgin; E Fattal; J P Andreux; P Couvreur
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

8.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

9.  New developments in surgery of malignant gliomas.

Authors:  Andrej Vranic
Journal:  Radiol Oncol       Date:  2011-07-20       Impact factor: 2.991

10.  Hyperthermia-induced targeting of thermosensitive gene carriers to tumors.

Authors:  Alenka Schwerdt; Arkadi Zintchenko; Massimo Concia; Nick Roesen; Kerry Fisher; Lars H Lindner; Rolf Issels; Ernst Wagner; Manfred Ogris
Journal:  Hum Gene Ther       Date:  2008-11       Impact factor: 4.793

View more
  8 in total

Review 1.  Multifunctional Inorganic Nanoparticles: Recent Progress in Thermal Therapy and Imaging.

Authors:  Kondareddy Cherukula; Kamali Manickavasagam Lekshmi; Saji Uthaman; Kihyun Cho; Chong-Su Cho; In-Kyu Park
Journal:  Nanomaterials (Basel)       Date:  2016-04-18       Impact factor: 5.076

2.  Morphological Changes and Cellular Uptake of Functionalized Graphene Oxide Loaded with Protocatechuic Acid and Folic Acid in Hepatocellular Carcinoma Cancer Cell.

Authors:  Kalaivani Buskaran; Mohd Zobir Hussein; Mohamad Aris Mohd Moklas; Sharida Fakurazi
Journal:  Int J Mol Sci       Date:  2020-08-16       Impact factor: 5.923

Review 3.  The Role of Graphene Oxide Nanocarriers in Treating Gliomas.

Authors:  Bin Wang; Hanfei Guo; Haiyang Xu; Yong Chen; Gang Zhao; Hongquan Yu
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

4.  Enhanced fluorescence/magnetic resonance dual imaging and gene therapy of liver cancer using cationized amylose nanoprobe.

Authors:  Hanchen Zhang; Li Deng; Haiqing Liu; Siyao Mai; Ziliang Cheng; Guangzi Shi; Hong Zeng; Zhuo Wu
Journal:  Mater Today Bio       Date:  2022-02-15

5.  Anti-Fn14-Conjugated Prussian Blue Nanoparticles as a Targeted Photothermal Therapy Agent for Glioblastoma.

Authors:  Nicole F Bonan; Debbie K Ledezma; Matthew A Tovar; Preethi B Balakrishnan; Rohan Fernandes
Journal:  Nanomaterials (Basel)       Date:  2022-08-01       Impact factor: 5.719

Review 6.  Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable.

Authors:  Amir Barzegar Behrooz; Zahra Talaie; Amir Syahir
Journal:  Pharmaceutics       Date:  2022-08-15       Impact factor: 6.525

7.  Graphene Oxide Loaded with Protocatechuic Acid and Chlorogenic Acid Dual Drug Nanodelivery System for Human Hepatocellular Carcinoma Therapeutic Application.

Authors:  Kalaivani Buskaran; Mohd Zobir Hussein; Mohamad Aris Mohd Moklas; Mas Jaffri Masarudin; Sharida Fakurazi
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

8.  Anti-Angiogenic and Anti-Proliferative Graphene Oxide Nanosheets for Tumor Cell Therapy.

Authors:  Valeria Verde; Anna Longo; Lorena Maria Cucci; Vanessa Sanfilippo; Antonio Magrì; Cristina Satriano; Carmelina Daniela Anfuso; Gabriella Lupo; Diego La Mendola
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.